Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17184756rdf:typepubmed:Citationlld:pubmed
pubmed-article:17184756lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:17184756lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:17184756lifeskim:mentionsumls-concept:C0123759lld:lifeskim
pubmed-article:17184756lifeskim:mentionsumls-concept:C0020964lld:lifeskim
pubmed-article:17184756lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:17184756lifeskim:mentionsumls-concept:C0175668lld:lifeskim
pubmed-article:17184756lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:17184756pubmed:issue1lld:pubmed
pubmed-article:17184756pubmed:dateCreated2007-2-26lld:pubmed
pubmed-article:17184756pubmed:abstractTextBrucella spp. cause disease in humans and livestock and are potential biowarfare agents. Defining the protective immune response is necessary to design vaccines. This has largely been done with mice, brucella-susceptible BALB/c and resistant C57BL strains. Since interferon-gamma is key to brucella resistance, contrary to expectations, we found that ex vivo splenocytes from naïve BALB/c mice produced IL-12 and interferon-gamma in cultures with brucellae at levels comparable to those of splenocytes from the more resistant C57BL/10 mice. Moreover, both IL-12 and interferon-gamma were produced in the first week following infection of BALB/c mice. However, by the third week of infection we found decreased IL-12Rbeta2 expression by BABL/c splenocytes, corresponding to their inability to produce interferon-gamma in Brucella recall responses at this time as reported previously. Administering recombinant IL-12 to these mice ameliorated the interferon-gamma hiatus, resulted in a 1000-fold reduction in CFU during primary infection and increased survival following secondary challenge.lld:pubmed
pubmed-article:17184756pubmed:languageenglld:pubmed
pubmed-article:17184756pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17184756pubmed:citationSubsetIMlld:pubmed
pubmed-article:17184756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17184756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17184756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17184756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17184756pubmed:statusMEDLINElld:pubmed
pubmed-article:17184756pubmed:monthSeplld:pubmed
pubmed-article:17184756pubmed:issn0008-8749lld:pubmed
pubmed-article:17184756pubmed:authorpubmed-author:BaldwinCynthi...lld:pubmed
pubmed-article:17184756pubmed:authorpubmed-author:MurphyErin...lld:pubmed
pubmed-article:17184756pubmed:authorpubmed-author:ParentMichell...lld:pubmed
pubmed-article:17184756pubmed:authorpubmed-author:FoulkesAndrea...lld:pubmed
pubmed-article:17184756pubmed:authorpubmed-author:BensonRita...lld:pubmed
pubmed-article:17184756pubmed:authorpubmed-author:Sathiyaseelan...lld:pubmed
pubmed-article:17184756pubmed:authorpubmed-author:GoenkaRadhika...lld:pubmed
pubmed-article:17184756pubmed:authorpubmed-author:FernandesDanc...lld:pubmed
pubmed-article:17184756pubmed:issnTypePrintlld:pubmed
pubmed-article:17184756pubmed:volume243lld:pubmed
pubmed-article:17184756pubmed:ownerNLMlld:pubmed
pubmed-article:17184756pubmed:authorsCompleteYlld:pubmed
pubmed-article:17184756pubmed:pagination1-9lld:pubmed
pubmed-article:17184756pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:17184756pubmed:meshHeadingpubmed-meshheading:17184756...lld:pubmed
pubmed-article:17184756pubmed:meshHeadingpubmed-meshheading:17184756...lld:pubmed
pubmed-article:17184756pubmed:meshHeadingpubmed-meshheading:17184756...lld:pubmed
pubmed-article:17184756pubmed:meshHeadingpubmed-meshheading:17184756...lld:pubmed
pubmed-article:17184756pubmed:meshHeadingpubmed-meshheading:17184756...lld:pubmed
pubmed-article:17184756pubmed:meshHeadingpubmed-meshheading:17184756...lld:pubmed
pubmed-article:17184756pubmed:meshHeadingpubmed-meshheading:17184756...lld:pubmed
pubmed-article:17184756pubmed:meshHeadingpubmed-meshheading:17184756...lld:pubmed
pubmed-article:17184756pubmed:meshHeadingpubmed-meshheading:17184756...lld:pubmed
pubmed-article:17184756pubmed:meshHeadingpubmed-meshheading:17184756...lld:pubmed
pubmed-article:17184756pubmed:meshHeadingpubmed-meshheading:17184756...lld:pubmed
pubmed-article:17184756pubmed:meshHeadingpubmed-meshheading:17184756...lld:pubmed
pubmed-article:17184756pubmed:year2006lld:pubmed
pubmed-article:17184756pubmed:articleTitleTreatment of Brucella-susceptible mice with IL-12 increases primary and secondary immunity.lld:pubmed
pubmed-article:17184756pubmed:affiliationDepartment of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA 01003, USA.lld:pubmed
pubmed-article:17184756pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17184756pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:17184756pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17184756pubmed:publicationTypeEvaluation Studieslld:pubmed
entrez-gene:16162entrezgene:pubmedpubmed-article:17184756lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17184756lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17184756lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17184756lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17184756lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17184756lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17184756lld:pubmed